Advancements in HER2-Positive Breast Cancer Treatment

This chapter explores recent progress in therapies for HER2-positive breast cancer, emphasizing improved progression-free survival rates with new experimental treatments. The discussion highlights the implications for first-line therapies and the integration of targeted therapies while addressing challenges like accessibility and patient selection.